Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Blood Glucose Monitoring System Market by Product, Testing Site, Patient Care Setting, Application - Global Forecast to 2022 - Research and Markets

Research and Markets
Posted on: 22 Dec 17

The "Blood Glucose Monitoring System Market by Product, Testing Site, Patient Care Setting, Application - Global Forecast to 2022" report has been added to Research and Markets' offering.

The global blood glucose monitoring system market is projected to reach USD 10.58 billion by 2022 from an estimated USD 8.35 billion in 2017, at a CAGR of 4.8% during the forecast period.

The key factors driving the growth of this market include rising prevalence of diabetic population, and increasing product launches. However, the high cost and poor reimbursements is expected to restrain the growth of this market during the forecast period.

Based on patient care setting, the market is segmented into self/home care and hospitals/clinics. The self/home care segment is expected to account for the largest share of the blood glucose monitoring system market. This can be attributed to high adoption of these devices for home use owing to technological advancements increasing their accuracy and patient comfort.

Based on application, the market is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes.

The type 1 diabetes segment is expected to grow at a highest CAGR owing to increasing product launches of continuous glucose monitors that are used for better management of type 1 diabetes.

North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to rising prevalence of diabetes in the US and Canada, favorable reimbursements, awareness programs and rising FDA approvals in the US.

Key Topics Covered:

1 Blood Glucose Monitoring System Market: Introduction

2 Blood Glucose Monitoring System Market: Research Methodology

3 Blood Glucose Monitoring System Market: Executive Summary

4 Blood Glucose Monitoring System Market: Premium Insights

5 Blood Glucose Monitoring System Market: Overview

6 Blood Glucose Monitoring System Market, By Product

7 Blood Glucose Monitoring System Market, By Testing Site

8 Blood Glucose Monitoring System Market, By Patient Care Setting

9 Blood Glucose Monitoring System Market, By Application

10 Blood Glucose Monitoring System Market, By Region

11 Blood Glucose Monitoring System Market: Competitive Landscape

12 Company Profiles

  • Abbott Laboratories
  • Acon Laboratories
  • Arkray
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • Dexcom
  • F. Hoffmann-La Roche
  • Lifescan
  • Medtronic
  • Nipro
  • Nova Biomedical
  • Prodigy Diabetes Care
  • Sanofi
  • Ypsomed

For more information about this report visit https://www.researchandmarkets.com/research/jq34hp/blood_glucose?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20171222005085/en/

Business Wire
www.businesswire.com

Last updated on: 22/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.